A BILL 
To direct the Secretary of Defense to include in periodic 
health assessments of members of the Armed Forces 
an evaluation of whether the member has been exposed 
to perfluoroalkyl substances and polyfluoroalkyl sub-
stances, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘PFAS Exposure As-
4
sessment and Documentation Act’’. 
5
19:43 Nov 05, 2020
H8643
2 
•HR 8643 IH
SEC. 2. INCLUSION OF EXPOSURE TO PERFLUOROALKYL 
1
AND POLYFLUOROALKYL SUBSTANCES AS 
2
PART OF PERIODIC HEALTH ASSESSMENTS. 
3
(a) PERIODIC HEALTH ASSESSMENT.—The Sec-
4
retary of Defense shall ensure that any periodic health as-
5
sessment provided to a member of the Armed Forces in-
6
cludes an evaluation of whether the member has been— 
7
(1) based or stationed at a military installation 
8
identified by the Department of Defense as a loca-
9
tion with a known or suspected release of 
10
perfluoroalkyl substances or polyfluoroalkyl sub-
11
stances during the period in which the member was 
12
based or stationed at the military installation; or 
13
(2) exposed to such substances, including by 
14
evaluating any information in the health record of 
15
the member. 
16
(b) SEPARATION HISTORY AND PHYSICAL EXAMINA-
17
TIONS.—Section 1145(a)(5) of title 10, United States 
18
Code, is amended by adding at the end the following new 
19
subparagraph: 
20
‘‘(C) The Secretary concerned shall ensure that each 
21
physical examination of a member under subparagraph 
22
(A) includes an assessment of whether the member was— 
23
‘‘(i) based or stationed at a military installation 
24
identified by the Department as a location with a 
25
known or suspected release of perfluoroalkyl sub-
26
19:43 Nov 05, 2020
H8643
3 
•HR 8643 IH
stances or polyfluoroalkyl substances during the pe-
1
riod in which the member was based or stationed at 
2
the military installation; or 
3
‘‘(ii) exposed to such substances, including by 
4
assessing any information in the health record of the 
5
member.’’. 
6
(c) 
DEPLOYMENT
ASSESSMENTS.—Section 
7
1074f(b)(2) of title 10, United States Code, is amended 
8
by adding at the end the following new subparagraph: 
9
‘‘(D) An assessment of whether the member 
10
was— 
11
‘‘(i) based or stationed at a military instal-
12
lation identified by the Department as a loca-
13
tion with a known or suspected release of 
14
perfluoroalkyl substances or polyfluoroalkyl sub-
15
stances during the period in which the member 
16
was based or stationed at the military installa-
17
tion; or 
18
‘‘(ii) exposed to such substances, including 
19
by assessing any information in the health 
20
record of the member.’’. 
21
19:43 Nov 05, 2020
H8643
4 
•HR 8643 IH
SEC. 3. PROVISION OF BLOOD TESTING FOR MEMBERS OF 
1
THE ARMED FORCES, FORMER MEMBERS OF 
2
THE ARMED FORCES, AND THEIR FAMILIES 
3
TO 
DETERMINE 
EXPOSURE 
TO 
4
PERFLUOROALKYL 
SUBSTANCES 
OR 
5
6
(a) MEMBERS OF THE ARMED FORCES.— 
7
(1) IN GENERAL.—If a covered evaluation of a 
8
member of the Armed Forces results in a positive 
9
determination of potential exposure to perfluoroalkyl 
10
substances or polyfluoroalkyl substances, the Sec-
11
retary of Defense shall provide to that member, dur-
12
ing that covered evaluation, blood testing to deter-
13
mine and document potential exposure to such sub-
14
stances. 
15
(2) INCLUSION IN HEALTH RECORD.—The re-
16
sults of blood testing of a member of the Armed 
17
Forces conducted under paragraph (1) shall be in-
18
cluded in the health record of the member. 
19
(b) FORMER MEMBERS OF THE ARMED FORCES AND 
20
FAMILY MEMBERS.—The Secretary shall pay for blood 
21
testing to determine and document potential exposure to 
22
perfluoroalkyl substances or polyfluoroalkyl substances for 
23
any covered individual, at the election of the individual, 
24
either through the TRICARE program for individuals oth-
25
19:43 Nov 05, 2020
H8643
5 
•HR 8643 IH
erwise eligible for such program or through the use of 
1
vouchers to obtain such testing. 
2
(c) DEFINITIONS.—In this section: 
3
(1) COVERED
EVALUATION.—The term ‘‘cov-
4
ered evaluation’’ means— 
5
(A) a periodic health assessment conducted 
6
in accordance with section 2(a); 
7
(B) a separation history and physical ex-
8
amination conducted under section 1145(a)(5) 
9
of title 10, United States Code, as amended by 
10
section 2(b); and 
11
(C) a deployment assessment conducted 
12
under section 1074f(b)(2) of such title, as 
13
amended by section 2(c). 
14
(2) COVERED INDIVIDUAL.—The term ‘‘covered 
15
individual’’ means a former member of the Armed 
16
Forces or a family member of a member or former 
17
member of the Armed Forces who lived at a location 
18
(or the surrounding area of such a location) identi-
19
fied by the Department of Defense as a location 
20
with a known or suspected release of perfluoroalkyl 
21
substances or polyfluoroalkyl substances during the 
22
period in which the individual lived at that location 
23
(or surrounding area). 
24
19:43 Nov 05, 2020
H8643
6 
•HR 8643 IH
(3) 
TRICARE 
PROGRAM.—The 
term 
1
‘‘TRICARE program’’ has the meaning given that 
2
term in section 1072(7) of title 10, United States 
3
Code. 
4
SEC. 
4. 
DOCUMENTATION 
OF 
EXPOSURE 
TO 
5
PERFLUOROALKYL 
SUBSTANCES 
OR 
6
7
(a) SHARING OF INFORMATION.—The Secretary of 
8
Defense and the Secretary of Veterans Affairs shall enter 
9
into a memorandum of understanding providing for the 
10
sharing by the Department of Defense with the Depart-
11
ment of Veterans Affairs of the results of covered evalua-
12
tions regarding the exposure by a member of the Armed 
13
Forces to perfluoroalkyl substances or polyfluoroalkyl sub-
14
stances. 
15
(b) REGISTRY.— 
16
(1) ESTABLISHMENT.—The Secretary of De-
17
fense shall establish a registry of members of the 
18
Armed Forces who have been exposed to, or are sus-
19
pected to have been exposed to, perfluoroalkyl sub-
20
stances or polyfluoroalkyl substances. 
21
(2) INCLUSION
IN
REGISTRY.—The Secretary 
22
shall include a member of the Armed Forces in the 
23
registry established under paragraph (1) if a covered 
24
19:43 Nov 05, 2020
H8643
7 
•HR 8643 IH
evaluation of the member establishes that the mem-
1
ber— 
2
(A) was based or stationed at a location 
3
identified by the Department of Defense as a 
4
location with a known or suspected release of 
5
perfluoroalkyl substances or polyfluoroalkyl sub-
6
stances during the period in which the member 
7
was based or stationed at the location; or 
8
(B) was exposed to such substances. 
9
(3) BLOOD TESTING.—The results of any blood 
10
test conducted under section 3(a) shall be included 
11
in the registry established under paragraph (1) for 
12
any member of the Armed Forces included in the 
13
registry. 
14
(4) ELECTION.—A member of the Armed 
15
Forces may elect not to be included in the registry 
16
established under paragraph (1). 
17
(c) PROVISION OF INFORMATION.—The Secretary of 
18
Defense shall provide to a member of the Armed Forces 
19
more information on perfluoroalkyl substances and 
20
polyfluoroalkyl substances and the potential impact of ex-
21
posure to such substances if a covered evaluation of such 
22
member establishes that the member— 
23
(1) was based or stationed at a location identi-
24
fied by the Department of Defense as a location 
25
19:43 Nov 05, 2020
H8643
8 
•HR 8643 IH
with a known or suspected release of perfluoroalkyl 
1
substances or polyfluoroalkyl substances during the 
2
period in which the member was based or stationed 
3
at the location; or 
4
(2) was exposed to such substances. 
5
(d) RULE OF CONSTRUCTION.—Nothing in this sec-
6
tion may be construed to preclude eligibility of a veteran 
7
for benefits under the laws administered by the Secretary 
8
of Veterans Affairs by reason of the exposure of the vet-
9
eran to perfluoroalkyl substances or polyfluoroalkyl sub-
10
stances not being recorded in a covered evaluation. 
11
(e) COVERED EVALUATION DEFINED.—In this sec-
12
tion, the term ‘‘covered evaluation’’ means— 
13
(1) a periodic health assessment conducted in 
14
accordance with section 2(a); 
15
(2) a separation history and physical examina-
16
tion conducted under section 1145(a)(5) of title 10, 
17
United States Code, as amended by section 2(b); 
18
and 
19
(3) a deployment assessment conducted under 
20
section 1074f(b)(2) of such title, as amended by sec-
21
tion 2(c). 
22
Æ 
19:43 Nov 05, 2020
H8643
